HDAC8 and fatty liver disease: It mitigates alcoholic hepatitis by curbing hdac8‐driven inflammatory responses [26] and alleviates hepatic steatosis while inhibiting hepatitis C virus replication through glycerol kinase targeting [27], implying a dual modulatory role in inflammation and metabolism within WD contexts.